Pei‐Yao Fu

IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

Bo Hu, Mincheng Yu, Xiaolu Ma et al. · Cancer Discovery · 2022 · 192 citations

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway

Chenhao Zhou, Chunxiao Liu, Wenjie Liu et al. · Theranostics · 2020 · 128 citations · Full text

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma

Jian Wang, Ao Huang, Yupeng Wang et al. · Annals of Translational Medicine · 2020 · 62 citations · Full text

NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells

Bo Hu, Guangyu Ding, Pei‐Yao Fu et al. · Journal of Hematology & Oncology · 2018 · 51 citations · Full text

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy

Mincheng Yu, Zheng Chen, Qiang Zhou et al. · Journal of Hepatology · 2022 · 49 citations · Full text